U.S. markets closed
  • S&P 500

    4,471.37
    +33.11 (+0.75%)
     
  • Dow 30

    35,294.76
    +382.20 (+1.09%)
     
  • Nasdaq

    14,897.34
    +73.91 (+0.50%)
     
  • Russell 2000

    2,265.65
    -8.52 (-0.37%)
     
  • Crude Oil

    82.66
    +1.35 (+1.66%)
     
  • Gold

    1,768.10
    -29.80 (-1.66%)
     
  • Silver

    23.35
    -0.13 (-0.54%)
     
  • EUR/USD

    1.1606
    +0.0005 (+0.05%)
     
  • 10-Yr Bond

    1.5760
    +0.0570 (+3.75%)
     
  • GBP/USD

    1.3751
    +0.0074 (+0.54%)
     
  • USD/JPY

    114.2000
    +0.5230 (+0.46%)
     
  • BTC-USD

    62,143.18
    +2,519.30 (+4.23%)
     
  • CMC Crypto 200

    1,464.06
    +57.32 (+4.07%)
     
  • FTSE 100

    7,234.03
    +26.32 (+0.37%)
     
  • Nikkei 225

    29,068.63
    +517.70 (+1.81%)
     

SHAREHOLDER ALERT: WeissLaw LLP Reminds CRSA, IPOE, VSPR, and CBMG Shareholders About Its Ongoing Investigations

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, Jan. 22, 2021 /PRNewswire/ --

WeissLaw LLP (PRNewsfoto/WeissLaw LLP)
WeissLaw LLP (PRNewsfoto/WeissLaw LLP)

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Crescent Acquisition Corp (NASDAQ: CRSA)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Crescent Acquisition Corp (NASDAQ: CRSA) in connection with the company's proposed merger with privately-held LiveVox Holdings, Inc. ("LiveVox"). Crescent will acquire LiveVox through a reverse merger that will result in LiveVox becoming a publicly traded company. If you own CRSA shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/crsa/

Social Capital Hedosophia Holdings Corp. V (NYSE: IPOE)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Social Capital Hedosophia Holdings Corp. V (NYSE: IPOE) in connection with the company's proposed merger with privately-held financial services platform Social Finance, Inc. ("SoFi"). If you own IPOE shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/ipoe/

Vesper Healthcare Acquisition Corp. (NASDAQ: VSPR)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Vesper Healthcare Acquisition Corp. (NASDAQ: VSPR) in connection with the company's proposed merger with privately-held The HydraFacial Company ("HydraFacial"). Under the terms of the agreement, VSPR will acquire HydraFacial through a reverse merger that will result in HydraFacial becoming a publicly traded company. If you own VSPR shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/vspr/

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) in connection with the proposed interested-party acquisition of the company by an entity consisting of CBMG's CEO Tony Liu, members of the company's management, and a consortium of investors. Under the terms of the agreement, shareholders will receive $19.75 in cash for each share of CBMG common stock that they own. If you own CBMG shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/cellular-biomedicine-group-inc/

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-crsa-ipoe-vspr-and-cbmg-shareholders-about-its-ongoing-investigations-301213441.html

SOURCE WeissLaw LLP